November 2025
The global lung cancer diagnostics market size is estimated at USD 5.35 billion in 2025 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
June 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
June 2026
The global lung cancer surgery market size was evaluated at USD 1.55 billion in 2025 and is predicted to hit around USD 2.76 billion by 2035, growing at a CAGR of 5.95%.
May 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 19.16 billion in 2025, with a CAGR of 9.25%.
February 2026
The global metastatic non-small cell lung cancer market size was evaluated at USD 18.50 billion in 2025 and is predicted to hit around USD 50.30 billion by 2035, growing at a CAGR of 10.52%.
February 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 9.72 billion in 2025, with a CAGR of 6.36%.
February 2026
The global cancer diagnostics market size was exhibited at USD 170 billion in 2025 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
January 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 173.13 billion in 2025, with a CAGR of 7.32%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
December 2025
The global gastric cancer diagnostics market size is evaluated at USD 1.32 billion in 2025 and is predicted to hit around USD 2.72 billion by 2035, growing at a CAGR of 7.51%.
February 2025
The lung cancer therapeutics market size is valued at USD 35.37 billion in 2025 and is expected to hit around USD 76.65 billion by 2035, growing at a CAGR of 8.04%.
February 2025
The global blood cancer diagnostics market size is estimated to hit around USD 21.24 billion by 2034 increasing from USD 10.90 billion in 2024, with a CAGR of 6.90%.
July 2025
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,500 million by 2034 from USD 790 million in 2024 with a notable CAGR of 12.21%.
July 2025
The global biopsy needle market size is expected to attain around USD 2.82 billion by 2034 from USD 1.39 billion in 2024 with a CAGR of 7.33%.
July 2026
The global point-of-care molecular diagnostics market size was valued at USD 8.95 billion in 2025 and is expected to hit around USD 13.06 billion by 2035, at a CAGR of 3.85%.
July 2026
The U.S. tuberculosis diagnostics market size was evaluated at USD 576.00 million in 2025 and is predicted to hit around USD 968.67 million by 2035, growing at a CAGR of 5.34%.
July 2026
The global genomics in cancer care market size was evaluated at USD 24.39 billion in 2025 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
July 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
July 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17Â million in 2026, with a CAGR of 5.09%.
July 2026
The global tissue diagnostics market size is expected to increase from USD 5.77 billion in 2025 and is projected to hit around USD 10.99 billion by 2035 with a CAGR of 6.66%.
July 2026
The global cancer biomarkers market size was estimated at USD 15.58 billion in 2025 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
June 2026
The global pancreatic cancer precision medicine market size is estimated to hit around USD 4,611.83 million 2035 increasing from USD 823.30 million in 2025, with a CAGR of 18.80%.
June 2026
The global veterinary point of care diagnostics market size is estimated to hit around USD 7.87 billion by 2035 from USD 2.96 billion in 2025, with a CAGR of 10.27%.
June 2026
The global in vitro diagnostics (IVD) market size accounted for USD 104.01 billion in 2025 and is expected to reach USD 135.76 billion by 2035.
June 2026
The global preeclampsia diagnostics market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.75 billion by 2035, growing at a CAGR of 3.10%.
June 2026
The global CRISPR-based diagnostics market size is evaluated at USD 3.79 billion in 2025 and is predicted to hit around USD 17.09 billion by 2035, growing at a CAGR of 16.25%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The rapid diagnostics market size was estimated at USD 51.12 billion in 2025 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com